In the present study, we aim to analyze the differential molecular/genetic changes in the EGFR/PI3K/AKT/PTEN pathway and the BCL2 family members BAX and BCL2 between low- and high-grade gliomas. This evidence concerns the gene BCL2 and central nervous system cancer.